Digital Trends in Healthcare: A Foretaste of the New Era of Science through Telemedicine
The year 2020 saw the horrific consequences of an unprepared healthcare landscape. Fortunately, it also witnessed mankind’s efforts to use everything at their disposal and rise to the occasion as warriors.
How relevant is the content of this newsletter to you?
MAT-IN-2400911 v.1.0-06/24
leave-site-modal-text
You are now being redirected to a third-party website.
Sanofi does not endorse or approve the content, products, services or opinions on the third-party website. Sanofi shall not be responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information on the third party website or any errors, omissions or inaccuracies and/or incompleteness of the information on the third party website.
Right answer: Both A and B. As per Diabetic & Ramadan guidelines, T2DM patients can safely continue glargine U-100 once daily at a reduced dose of 15 - 30% at Iftar1,2. Insulin glargine U-100 is safe to be used during Ramadan with no significant increase in hypoglycaemia3. One-on-one dietary educational session can also reduce the number of adverse events of fasting1.
.svg)
